- Enzene Biosciences Ltd. has partnered with Virtuosi®, an immersive training platform developed by Quality Executive Partners, Inc. (QxP), becoming the first Indian company to adopt this technology.
- The partnership aims to develop a highly skilled and globally competitive workforce in India’s rapidly growing biologics and biosimilars manufacturing sector.
Enzene Biosciences Ltd., a Continuously Innovative Development and Manufacturing Organization (CIDMO) in the biologics industry, has announced a strategic partnership with Virtuosi®, the IACET-accredited immersive training platform for pharmaceutical manufacturing developed by Quality Executive Partners, Inc. (QxP). With this collaboration, Enzene becomes the first Indian company to integrate Virtuosi, advancing its commitment to workforce excellence and global competitiveness.
The partnership comes as India’s pharmaceutical sector experiences strong growth, particularly in biologics and biosimilars. Virtuosi provides a scalable, virtual reality (VR)-based platform designed to enhance learning and compliance across aseptic processing, quality assurance, data integrity, and regulatory standards.
“By partnering with Virtuosi, we are investing not only in training excellence for our own teams, but also in setting a benchmark for the entire industry. This is about raising the standard for how medicines are made—safely, compliantly, and with world-class technical mastery.”
Sundar Ramanan, PhD, Chief Quality Officer at Enzene
Crystal Mersh, Chief Executive Officer and Founder of Quality Executive Partners, added that Enzene’s adoption of Virtuosi demonstrates vision and leadership within the CDMO sector, underscoring India’s commitment to workforce readiness and operational excellence.
